Monashee Investment Management »

Myriad Genetics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $957k 50k 19.14

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Myriad Genetics

Vanguard Group
Wellington Management Company
Glenview Captal Management
Earnest Partners
Millennium Management
Bank of America Corporation
Dimensional Fund Advisors
Artisan Partners Limited Partnership
D. E. Shaw & Co
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management
Bank of New York Mellon
Principal Financial Group
State Farm Mutual Automobile Insurance Company

View all funds holding Myriad Genetics